CAS 113048-69-4

(E)-3-(3-(trifluoromethyl)phenyl)prop-2-en-1-ol

Codes: CINA-009

Application context (from source-drug indications)

HypercalcaemiaCinacalcet HydrochlorideSecondary hyperparathyroidismCinacalcet HydrochlorideHyperparathyroidismCinacalcet HydrochloridePrimary hyperparathyroidismCinacalcet HydrochlorideChronic renal impairmentCinacalcet HydrochlorideCardiogenic oedemaCinacalcet Hydrochloride

Source drugs (routes using this intermediate)

Drug	Tier	Expiry
Cinacalcet Hydrochloride	Tier B — Position early	-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Cinacalcet HydrochlorideOptimised routesteps: 5total yield: /

1-bromo-3-(trifluoromethyl)benzene→3-(3-(trifluoromethyl)phenyl)propan-1-ol→(R)-1-(naphthalen-1-yl)ethan-1-amine→ethyl acrylate→ethyl (E)-3-(3-(trifluoromethyl)phenyl)acrylate→(E)-3-(3-(trifluoromethyl)phenyl)prop-2-en-1-ol→1-(3-chloropropyl)-3-(trifluoromethyl)benzene

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.